Longterm Impact of Living Liver Donation: A Self-Report of the Donation Experience.


Journal

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185

Informations de publication

Date de publication:
05 2019
Historique:
received: 30 05 2018
accepted: 19 12 2018
pubmed: 28 12 2018
medline: 21 7 2020
entrez: 28 12 2018
Statut: ppublish

Résumé

Outcomes for adult-to-adult living liver donors (LDs) are largely based on short-term data drawn from single-center studies. The aim of this study was to determine how living liver donation (LLD) impacts self-reported quality-of-life (QOL) up to 6 years after donation in a sample of residents from New York State. New York transplant programs are state-mandated to track LDs as part of a quality assurance and patient safety effort. Donor-reported QOL within 1 year of donation and longitudinal data over a 10-year period were analyzed. Self-reported surveys include the following domains: employment, finances, health/life insurance, activities of daily living, physical/emotional health, donor experience, relationships, and LD opinions. There were 220 LDs in New York (2004-2013) who completed a survey over the 10-year period with many donors completing surveys at several points in time. Overall, longterm LDs remain as comfortable about LLD as they were during the first year after donation (95%). The majority of LDs reported feeling as well as before LLD (72%). At 1 year after donation, 60% of subjects self-reported medical problems, and 30% reported emotional issues. However, the majority reported that they would willingly donate again. In conclusion, LDs remain satisfied with their decision to donate over time. A minority of LDs report longterm medical and emotional issues. The conclusions provide information for educational interventions to improve informed choice to those considering donation.

Identifiants

pubmed: 30589993
doi: 10.1002/lt.25402
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

724-733

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 by the American Association for the Study of Liver Diseases.

Auteurs

Dianne LaPointe Rudow (D)

Zweig Family Center for Living Donation, Recanati/Miller Transplantation Institute, Department of Health Evidence and Policy, Mount Sinai Hospital, New York, NY.

Samantha DeLair (S)

New York Center for Liver Transplantation, Troy, NY.

Thomas Feeley (T)

Incisive Research, Buffalo, NY.

Sander Florman (S)

Zweig Family Center for Living Donation, Recanati/Miller Transplantation Institute, Department of Health Evidence and Policy, Mount Sinai Hospital, New York, NY.

James Guarrera (J)

New York Presbyterian Hospital, New York, NY.

Milan Kinkhabwala (M)

Montefiore Medical Center, Bronx, NY.

Mark Orloff (M)

University of Rochester Medical Center, Rochester, NY.
Westchester Medical Center, Valhalla, NY.

Lewis Teperman (L)

North Shore University, New York, NY.

Glyn Morgan (G)

NYU Langone Medical Center, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH